Will gastric stromal tumor recur after surgery? It is easy to recur, so be careful

Gastric stromal tumors are prone to recurrence after surgery, which is closely related to the patient's condition. After surgery, you need to follow the doctor's advice, and postoperative rehabilitation treatment is also very important. After surgery, you can take anti-tumor Chinese patent medicine oral liquid, undergo surgical resection, choose targeted therapy, radiotherapy, etc., and choose the appropriate treatment method, so you must pay attention to it.

Gastrointestinal tumors are a type of malignant tumor, but they are not cancer. They are a type of tumor that originates from mesenchymal tissue. They are relatively less malignant than cancer and have a very good prognosis. Surgical treatment can usually achieve a cure. Gastrointestinal stromal tumors generally require surgery to treat. Will gastric stromal tumors recur after surgery?
The recurrence rate of gastric tumor after surgery has a grading system based on the degree of malignancy. The malignancy grading is mainly based on the size of the tumor and the nuclear division of the tumor to determine the malignancy of the tumor, which is divided into so-called low-risk, medium-risk, and high-risk. For low-risk patients, the risk of recurrence is very low. After the operation, basically no special treatment is required, and regular check-ups are sufficient.
For patients at medium and high risk, there is still a risk of recurrence, so they need to have regular checkups and take drugs to prevent recurrence. Currently, the drug that can inhibit or control tumor recurrence and metastasis is imatinib, which is recommended for patients at medium and high risk.
A successful operation is an important step in anti-tumor treatment for early-stage cancer patients. Postoperative rehabilitation treatment is crucial. After the operation, you can add oral anti-tumor Chinese patent medicine liquid, which is easy to take, further consolidates the therapeutic effect, and effectively prevents recurrence and metastasis.
Symptoms of gastric stromal tumors include nausea, vomiting, abdominal pain, black stools, and anemia, but these symptoms can also be seen in other digestive system diseases, so they are easily overlooked. Among patients with gastrointestinal stromal tumors who visit the doctor for the first time, 20% to 30% are in the advanced stage, and 11% to 47% have liver metastasis or abdominal metastasis, missing the best time for treatment.
"The current thinking is that gastric stromal tumors are basically malignant, and seemingly benign stromal tumors will eventually become malignant." The malignancy of gastric tumors is roughly divided into: ultra-low risk (tumor <2cm), low risk (tumor 2cm-5cm), medium risk (tumor 5cm-10cm) and high risk (tumor >10cm). Low-risk, low-risk and medium-risk patients have a better prognosis and are less likely to relapse and metastasize after surgical resection, while high-risk patients are prone to relapse and metastasis. Since gastrointestinal stromal tumors are insensitive to radiotherapy and chemotherapy, with the advent of molecular targeted drugs, in addition to surgery, targeted therapy can also be chosen.